Evaluation of a Commercial Culture-Free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison With an Antireceptor-Binding Domain Enzyme-Linked Immunosorbent Assay.
Jesse PapenburgMatthew P ChengRachel CorsiniChelsea CayaEmelissa MendozaKathy ManguiatL Robbin LindsayHeidi WoodMichael A DrebotAntonia DibernardoGerasimos ZaharatosReneé BazinRomain GasserMehdi BenlarbiGabrielle Gendron-LepageGuillaume Beaudoin-BussièresJérémie PrévostAndrés FinziMomar NdaoCedric P YansouniPublished in: Open forum infectious diseases (2021)
The added value of cPass compared with an IgG anti-RBD ELISA was modest.